Substituted lactose derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5361231, 53612313, 536124, C07H 304, C07H 306, C07H 1504

Patent

active

055918352

ABSTRACT:
Compounds and methods of making them having the following formula are described which bind to selectin receptors and thus modulate the course of inflammation, cancer and related diseases by modulating cell-cell adhesion events: ##STR1## wherein each R.sup.1 is independently H or lower alkyl (1-4C); R.sup.2 is H, OH or lower alkyl (1-4C), or a lipophilic group such as a higher alkyl group (5-15C), alkylaryl or one or more additional saccharide residues;
R.sup.3 is a negatively charged moiety including SO.sub.4.sup.2-, PO.sub.4.sup.2-, or related group;
Y is H or lower alkyl (1-4C); and
X is H or --CHR.sub.4 (CHOR.sup.1).sub.2 CHR.sup.5 OR.sup.1 wherein R.sup.4 and R.sup.5 are each independently H, lower alkyl (1-4C), or taken together result in a five- or six-membered ring optionally containing a heteroatom selected from the group consisting of O, S, and NR.sup.1 ;
the five- or six-membered ring optionally substituted with one substituent selected from the group consisting of R.sup.1, CH.sub.2 OR.sup.1, OR.sup.1, OOCR.sup.1, NR.sup.1.sub.2, NHCOR.sup.1, and SR.sup.1 with the proviso that if X represents a hexose substituent R.sup.3 and R.sup.4, taken together, cannot provide a hexose substituent.

REFERENCES:
patent: 4661345 (1987-04-01), Tuomanen
patent: 4994441 (1991-02-01), Neeser
Biochem. Biophys. Res. Comm. 20(1):60-62 (1965).
Carbohydr. Res. 154:93-101 (1986).
J. Am. Chem. Soc. 97(14):4069-4075 (1975).
Methods in Carbohydrate Chemistry, Whistler et al, eds. Academic Press, New York, 1972, pp. 426-429.
Article by Yuen, et al., entitled "Novel Sulfated Ligands for the Cell Adhesion Molecule E-Selectin Revealed by the Neoglycolipid Technology among O-Linked Oligosaccharides on an Ovarian Cystadenoma Glycoprotein" published by American Chemical Society, (1992) pp. 9126-9131.
Article by Jain, et al., entitled "A Convenient Synthesis of O-.alpha.-L-fucopyranosyl-(1.fwdarw.2)-O-.beta.-D galactopyranosyl-(1.fwdarw.4)-D glucopyranose (2'-O-.alpha.-L-fucopyranosyllactose)" published by Elsevier Science Publishers B.V., (1991), pp. c-1-c-3.
Chandrasekaran et al.; Abstract--Abstracts of the 11th International Symposium On Glycoconjugates: (Jun. 30-Jul. 5, 1991).
Hakomori et al., Biochem. Biophys. Res. Commun. 100(4):1578-86 (1981).
Gooi et al.; Nature 292:156-8 (1981).
Shur; J. Biol. Chem. 257(12):6871-8 (1982).
Bird et al.: Devel. Biol. 104:449-60 (1984).
Fenderson et al.: J. Exp. Med. 160:1591-6 (1984).
Gabius et al.,; Anticancer Res. 6:573-8 (1986).
Lis et al.; Ann. Rev. Biochem. 55:35-67 (1986).
Sato et al.: Carb. Res. 155: c6 c10 (1986).
Fenderson et al.; Dev. Biol. 122:21-34 (1987).
Dasgupta et al.; Carb. Res. 177:c13 c17 (1988).
Fenderson et al.; Differentiation 38:124-133 (1988).
Kojima et al.; J. Biol. Chem. 264(34):20159-62 (1989).
Eggens et al.; J. Biol. Chem. 264(16): 9476-84 (1989).
Fernandez-Mayoralas et al, Car. Res. 140:81-91 (Nov. 1985).
Mulligan, et al., "Role of Endothelial-Leukocyte Adhesion Molecule 1 (Elam-1) in Neutrophil-mediated Lung Injury in Rats," J. Clin. Invest, 88:1396-1406 (1991).
Bevilacqua, et al., "Identification of an inductible endothelial-leukocyte adhesion molecule", Proc. Natl. Acad. Sci., USA 84:9238-9242 (1987).
Ma, et al., "Monoclonal Antibody to L-Selectin Attenuates Neutrophil Accumulation and Protects Ischemic Reperfused Cat Myocardium," Circulation, 88:2:649-658 (Aug. 1993).
Entman, et al., "Inflammation in the course of early myocardial ischemia," FASEB Journal, vol. 5, pp. 2529-2537 (Aug. 1991).
Vedder, et al., "Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear," Proc. Natl. Acad. Sci. USA 87:2643-2646 (Apr. 1990).
Weyrich, et al., "In Vivo Neutralization of P-Selectin Protects Feline Heart and Endothelium in Myocardial Ischemia and Reperfusion Injury," J. Clin. Invest. 91:262-2629 (Jun. 1993).
Yamazaki, et al., "Expression of Intercellular Adhesion Molecule-1 in Rat Heart with Ischemia Reperfusion and Limitation in Infarct Size by Treatment with Antibodies against Cell Adhesion Molecules", Amer. Journal of Path. 143:2:410-418 (Aug. 1993).
Smith, et al., "Leukocyte Adhesion Molecules and Myocardial Ischemia," TMC 1:4:167-170 (1990).
Simpson, "Reduction of Experimental Canine Myocardial Reperfusion Injury by a Monoclonal Antibody (Anti-Mo1, Anti-CD11b) That Inhibits Leukocyte Adhesion," J. Clin. Invest. 81:624-629 (1988).
Winn, "Anti-P-Selectin Monoclonal Antibody Attenuates Reperfusion Injury to the Rabbit Ear," J. Clin. Invest. 92:2042-2047 (Oct. 1993).
Feizi, "Oligosaccharides that mediate mammalian cell-cell adhesion," Current Opinion in Structural Biology 3:701-710 (1993).
Kojima, "Inhibition of Selectin-Dependent Tumor Cell Adhesion to Endothelial Cells and Platelets by Blocking O-Glycosylation of these Cells," Biochem. and Biophys. Res. Comm. 182:3:1288-1295 (1992).
Varki, "Selectins and other mammalian sialic acid-binding lectins," Curr. Opin. in Cell Biology 4:257-266 (1992).
McEver, "GMP-140: A receptor for Neutrophils and Monocytes on Activated Platelets and Endothelium," Journ of Cellular Biochem. 45:156-161 (1991).
Edgington, "How Sweet it is: Selectin Mediating Drugs," Biotechnology, 10:383-389 (1992).
Geng, et al., "Rapid neutrophil adhesion to activated endothelium mediated by GMP-140," Nature, 343:757-760 (1990).
Green, et al., "High Affinity binding of the leucoyte adhesion L-Selectin to 3'-sulphated-lc.sup.a and le.sup.x oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides," Biochem and Biophys. Res. Comm. 188:1:244-251 (1992).
Foxall, et al., "The Three Members of the Selectin Receptor Family Recognize a Common Carbohydrate Epitope, the Sialyl Lewis.sup.x Oligosaccharide," Journal of Cell Biol., 117:4:895-902 (May 1992).
Yuen, et al., "Sulfated Blood Group Lewis.sup.a A Superior Oligosaccharide Ligand for Human E-Selectin," Journl. Biolog. Chem. 259:3:1595-1598 (1994) .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted lactose derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted lactose derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted lactose derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1765245

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.